Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy by Giunta A, Ventura A, Chimenti MS, Bianchi L, Esposito M

Connect to this object online.

Hepatitis B reactivation in psoriasis patients treated with anti-TNF agents: prevention and management by Cannizzaro MV, Franceschini C, Esposito M, Bianchi L, Giunta A

Connect to this object online.

Omalizumab for chronic spontaneous urticaria in “complex” patients: data from real-life clinical practice by Vollono L, Piccolo A, Lanna C, Esposito M, Bavetta M, Campione E, Bianchi L, Diluvio L

Connect to this object online.